Lipiarmycin and its preparation

Information

  • Patent Grant
  • 3978211
  • Patent Number
    3,978,211
  • Date Filed
    Thursday, October 31, 1974
    50 years ago
  • Date Issued
    Tuesday, August 31, 1976
    48 years ago
Abstract
The novel antibiotic, lipiarmycin, is prepared by cultivating Actinoplanes deccanensis A/10655, ATCC 21983, under aerobic conditions in a fermentation broth, from which it is then recovered.
Description

SUMMARY OF THE INVENTION
In the preparation of the novel antibiotic lipiarmycin, Actinoplanes deccanensis A/10655, which has been deposited and made part of the stock culture collection of ATCC, where it was assigned number 21983, is cultivated under aerobic conditions in an aqueous nutrient medium suitable for the growth of said organism, the medium containing a source of carbon, a source of nitrogen and inorganic salts. Ordinarily, the antibiotic-producing strain is pre-cultured in a shake flask until substantial antibiotic activity is present, then the culture is used to inoculate jar fermentors containing nutrient fermentative medium. Cultivation is continued at 25.degree.-35.degree.C under aerobic conditions for a time sufficient to produce a substantial antibiotic level. During this time, microbiological assays are carried out by the agar diffusion method to control the concentration of the antibiotic substance produced. The lipiarmycin is isolated from the fermentation broth by conventional procedures, such as, for instance, by extraction with an organic solvent in which the antibiotic substance is soluble and which is immiscible with the aqueous medium. Suitable organic solvents for such purpose are advantageously selected from halogenated C.sub.1 -C.sub.4 hydrocarbons and C.sub.4 -C.sub.6 alkanols. The solvent is then separated from the fermentation broth by high-speed centrifugation, concentrated to about 1/20-1/40 of its original volume and allowed to stand until the antibiotic substance precipitates.
The crude lipiarmycin is dissolved in a 90:10 chloroform:methanol mixture, chromatographed through a silica gel column and eluted with a mixture of chloroform and methanol in the same proportions as above. Lipiarmycin is finally crystallized from a mixture of diethyl ether and light petroleum.





DESCRIPTION OF THE PREFERRED EMBODIMENTS
Production of Lipiarmycin
To produce the antibiotic lipiarmycin, the strain Actinoplanes deccanensis A/10655 is aerobically pre-cultured in a nutrient medium until substantial antibiotic activity is present at a pH value ranging from about 6 to about 8. As an example, a shake flask culture may have the following composition in g./l.
______________________________________Meat extract 3.0Tryptone 5.0Yeast extract 5.0Glucose 1.0Soluble starch 24.0Calcium malate 4.0Distilled water q.s. to 1000 ml.______________________________________
The flasks are shaken for about 24 hours at about 28.degree.-30.degree.C., then the pre-cultures (one liter) are used to inoculate jar fermentors, each containing 10 liters of the following nutrient medium:
______________________________________Meat extract 40 g.Peptone 40 g.Yeast extract 10 g.Sodium chloride 25 g.Soybean meal 100 g.Glucose 500 g.Calcium carbonate 50 g.Tap water q.s. to 10 liters______________________________________
The fermentation batches are incubated aerobically under stirring at 28.degree.-30.degree.C. At intervals, the antibiotic activity is assayed microbiologically by the agar diffusion method using Staphylococcus aureus as the test organism. The maximum activity is reached after 72- 96 hours of fermentation.
Isolation of Lipiarmycin
When fermentation is completed the fermentation broth is extracted twice with an amount of butanol corresponding to 30 percent of its volume. The butanol solution is separated from the broth by high-speed centrifugation and is concentrated to about 1/20 of its original volume by evaporation under vacuum at 40.degree.-50.degree.C. The butanol solution so obtained is washed with water and the resulting two layers are separated. The organic layer is further concentrated to about 1/30 of its original volume and allowed to stand for about 3-7 hours at 4.degree.C. until a precipitate forms, which is recovered by filtration. By addition of light petroleum to the filtrate, further crude compound is obtained. From 10 liters of fermentation broth, 11 g. of antibiotic substance are recovered.
The so obtained crude lipiarmycin is dissolved in a 90:10 chloroform:methanol mixture and to the resulting solution a compatible amount of silica gel is added. The mixture is evaporated to dryness under vacuum at 40.degree.-50.degree.C., the solid obtained is added to the top of a silica gel column and the subsequent elution is carried out with a mixture of chloroform and methanol in the same proportions as above.
The so obtained purified antibiotic is dissolved in a small amount of methanol and to the resulting solution is added diethyl ether and the resulting solution is heated to about 40.degree.C. for a few minutes. Light petroleum is added to this warm solution until a slight opacity is observed, then the whole is allowed to stand at 3.degree.-6.degree.C. for one day. Pure lipiarmycin thereby precipitates, which is recovered by filtration and dried under vacuum.
Lipiarmycin as so produced is a white crystalline substance having the following properties:
1. Melting point: 173.degree.-75.degree.C. (from a mixture of methanol, diethyl ether and light petroleum)
2. Molecular weight: 1076 (potentiometric determination)
3. Elemental analysis: C 58.02%; H 6.94%; Cl 6.64%; O 28.40% (by difference)
4. U.V. absorption bands
In each of the below-outlined solvent systems, lipiarmycin shows the following values:
______________________________________Solvent max (m .mu.) E.sub.1 cm..sup.1%______________________________________methanol 232 354 268 (shoulder) 214 315 108phosphatebuffer pH 7.38 238 331 275 194hydrochloricacid 0.1 N 231 338 272 207sodium hydroxide0.1 N 235 370 270 (shoulder) 183______________________________________
The complete picture of the spectrum is given in accompanying FIG. 1.
5. Infrared Spectrum
Characteristic absorption bands occur at the following frequencies (cm. .sup.-.sup.1): 3600, 3450, 2900(Nujol), 1730, 1690, 1640, 1585, 1560, 1460(Nujol), 1380(Nujol), 1300, 1240, 1200, 1140, 1120, 1075, 1025, 990, 950, 915, 900, 890, 850, 820, 790, 780, 745, 720, 705.
A complete figure of the I.R. spectrum is given in accompanying FIG. 2.
6. Specific rotation: [.alpha. ] .sub.D.sup.20 (1.98 percent methanol) = -5.5.degree.
7. Proton Magnetic Resonance (P.M.R.) spectrum: see accompanying FIG. 3.
8. Solubility
Very soluble in ethanol, methanol, pyridine, aqueous sodium carbonate.
Fairly soluble in benzene, methylene chloride, chloroform, acetone, propanol.
Sparingly soluble to insoluble in water, buffered solution at pH 7, aqueous sodium bicarbonate, hexane.
9. Characteristic reactions
______________________________________Tollens positiveFeCl.sub.3 positiveH.sub.2 SO.sub.4 positiveSchiff negativeMillon negativeMaltole negative______________________________________
10. Acidity
An ionizable function is spectrophotometrically evidenced with pKa (in methyl cellosolve): 6.8
On the basis of microanalytical data, lipiarmycin may be assigned the following empirical formula: C.sub.52 H.sub.74 Cl.sub.2 O.sub.19.
The antibiotic substance of the invention is active against bacteria, and in particular against the following microorganisms at the indicated concentrations.
______________________________________ MINIMAL INHIBITORY CONCENTRATIONSTRAIN .gamma./ml.______________________________________Staphylococcus aureus ATCC 6538 2Staphylococcus aureus Tour 2Streptococcus hemolyticus C203 10Diplococcus pneumoniae UC 41 50Staphylococcus aureus Tour with 10 10percent bovine serumStreptococcus mutans ATCC 25175 0.5Mycobacterium tub. H37Rv ATCC 9360 50Mycoplasma gallisepticum H 21 C.Z.B. 50______________________________________
Lipiarmycin is also active against strains which are resistant to other antibiotics which are widely used in chemotherapeutic practice. As a representative example, in the following table the minimum inhibitory concentrations (M.I.C.), .gamma./ml., of lipiarmycin against Staphylococcus aureus strains resistant to several antibiotics are reported.
Table II______________________________________ M.I.C. M.I.C. of other ofSTRAIN antibiotics lipiarmycin______________________________________Staphylococcus aureusATCC 6538 resistantto penicillin penicillin >100 2Staphylococcus aureusATCC 6538 resistantto streptomycin streptomycin >100 5Staphylococcus aureusATCC 6538 resistantto tetracycline tetracycline >100 5Staphylococcus aureusATCC 6538 resistantto novobiocin novobiocin >100 2Staphylococcus aureusATCC 6538 resistantto neomycin neomycin >100 2Staphylococcus aureusATCC 6538 resistantto erythromycin erythromycin >100 5Staphylococcus aureusATCC 6538 resistantto chloramphenicol chloramphenicol >100 2Staphylococcus aureusATCC 6538 resistantto cephaloridine cephaloridine >100 5Staphylococcus aureusATCC 6538 resistantto streptothricin streptothricin >100 5Staphylococcus aureusATCC 6538 resistantto bacitracin bacitracin >100 5Staphylococcus aureusATCC 6538 resistantto oleandomycin oleandomycin 50 5______________________________________
These favorable antimicrobial properties are coupled with a very low toxicity, the LD.sub.50 value of lipiarmycin being about 500 mg./kg. i.p. in mice. Accordingly, the present invention provides a therapeutic composition comprising the compound of the invention together with a pharmaceutically-acceptable carrier.
Description of Actinoplanes deccanensis A/10655
This strain grows well on many agars. The surface is opaque and slightly rough to wrinkled. Aerial mycelium is always absent. At microscopic examination the vegetative mycelium is branched, with a diameter of about 1 .mu.. The sporangia form abundantly on soil extract agar and are globose with an irregular surface and a diameter ranging from 4-7 .mu.. After rupture of the wall of the sporangium, it is possible to observe spore release. The spores are sub-spherical and are motile (size 1 .mu. .times. 1.5 .mu.).
Table III reports the cultural characteristics of Actinoplanes deccanensis A/10655 when cultivated on various standard media suggested by Shirling and Gottlieb (Intern. J. Syst. Bact., 16, 313-340, 1966) and other media recommended by Waksman (The Actinomycetes, vol. II, The Williams and Wilkins Co., 1961). The cultural characteristics were determined after 6 to 14 days of incubation at 30.degree.C.
Table III______________________________________The numbers of some of the culture media refer tothose given by Shirling and Gottlieb.Culture Media Cultural Characteristics______________________________________Medium No. 2 (yeast Abundant growth, veryextract-malt agar) wrinkled, light orangeMedium No. 3 (Oatmeal Moderate growth, crusty,agar) light amberMedium No. 4 (Inorganic Abundant growth, crusty,salts-starch agar) orangeMedium No. 5 (Glycerol- Moderate growth, roughasparagine agar) surface, orangeMedium No. 6 (Peptone- Moderate growth, wrin-yeast extract-iron agar) kled, light orangeMedium No. 7 (Tyrosine Abundant growth, wrin-agar) kled, amber to light brown, diffusible brown, pigmentOatmeal agar according Abundant growth, crusty,to Waksman opaque, light orangeHickey and Tresner's Abundant growth, wrin-agar kled, light orange- pinkishCzapeck glucose agar Moderate growth, crusty, cream to light orangeGlucose asparagine Moderate growth, slight-agar ly crusty, opaque, cream to light orangeNutrient agar Moderate growth, crusty, opaque, light orangePotato agar Abundant growth, very wrinkled, pale orangeBennett's agar Abundant growth, wrin- kled, light orangeCalcium malate agar Scanty growth, wrinkled, opaque light orangeSkim milk agar Abundant growth, wrinkled, opaque orangeCzapeck agar Moderate growth, crusty, light orangeEgg agar Scanty growth, thin, opaque, white-waxyPeptone glucose agar Moderate growth, crusty, orangeAgar Very scant growth, thin, hyalineLoeffler serum Moderate growth, rough surface, orangePotato Moderate growth, wrinkled, light orangeGelatin Scanty growth, light orangeCellulose agar Very scanty growth, thin, hyaline______________________________________
The most convenient temperature for development of the colonies was found to range from about 18.degree. to about 42.degree.C.; the optimum temperature being from about 28.degree. to about 37.degree.C.
Table IV reports the utilization of carbon sources examined according to the method of Pridham and Gottlieb.
Table IV______________________________________Carbon sources Utilization______________________________________Inositol -Fructose -Rhamnose +Mannitol -Xylose +Raffinose -Arabinose +Cellulose -Sucrose +Glucose +Mannose +Lactose +Salicin -______________________________________
Following Table V reports the physiological characteristics of the strain.
Table V______________________________________TEST RESULTS______________________________________Hydrolysis of starch positiveH.sub.2 S formation negativeTyrosinase reaction positiveCasein hydrolysis negativeSolubilization of calcium malate positiveNitrate reduction positiveLiquefaction of gelatine positive coagulation negativeLitmus milk peptonization negativeCellulose decomposition negativeChromogenic action positive______________________________________
Claims
  • 1. An antibiotic named lipiarmycin having the following characteristics:
  • a. Melting point: 173.degree.-175.degree.C.
  • b. Molecular weight (potentiometric determination): 1076
  • c. Elemental analysis: C: 58.02%; H: 6.94%; Cl: 6.64%; O: 28.40% (by difference);
  • d. Characteristic U.V. absorption bands in the following solvent systems:
  • ______________________________________Solvent max(m .mu.) E.sub.1 cm..sup.1%______________________________________methanol 232 354 268 (shoulder) 214 315 108phosphatebuffer pH 7.38 238 331 275 194hydrochloricacid 0.1 N 231 338 272 207sodium hydroxide0.1 N 235 370 270 (shoulder) 183______________________________________
  • e. Characteristic infrared absorption bands in Nujol at the following frequencies (cm. .sup.-.sup.1): 3600, 3450, 2900(Nujol), 1730, 1690, 1640, 1585, 1560, 1460(Nujol), 1380(Nujol), 1300, 1240, 1200, 1140, 1120, 1075, 1025, 990, 950, 915, 900, 890, 850, 820, 790, 780, 745, 720, 705
  • f. Specific rotation [.alpha.] .sub.D.sup.20 (1.98% methanol)=-5.5.degree.
  • g. Solubility:
  • Very soluble in methanol, ethanol, pyridine, aqueous sodium carbonate;
  • Fairly soluble in benzene, methylene chloride, chloroform, acetone, propanol;
  • Sparingly soluble to insoluble in water, buffered solution at pH 7, aqueous sodium bicarbonate, hexane
  • h. Characteristic reactions:
  • Tollens: positive
  • FeCl.sub.3 : positive
  • H.sub.2 so.sub.4 : positive
  • Schiff: negative
  • Millon: negative
  • Maltole: negative
  • i. pKa in methylcellosolve:6.8
  • 2. A process for producing the antibiotic lipiarmycin which comprises aerobically cultivating the microorganism Actinoplanes deccanensis A/10655, ATCC 21983, in an aqueous nutrient medium containing assimilable sources of carbon, nitrogen and inorganic salts and recovering therefrom lipiarmycin formed during the culture.
  • 3. A culture containing the microorganism strain Actinoplanes deccanensis ATCC 21983, said culture being capable of producing the antibiotic lipiarmycin in a recoverable quantity upon aerobic fermentation in an aqueous nutrient medium containing assimilable sources of carbon, nitrogen and inorganic salts.
Priority Claims (1)
Number Date Country Kind
54170/73 Nov 1973 UK
Non-Patent Literature Citations (1)
Entry
miller, The Pfizer Handbook of Microbial Metabolites, McGraw-Hill Book Co., Inc., N. Y., N. Y., 1961, p. 118.